Establishment of Outcome-Related Analytic Performance Goals

被引:81
作者
Klee, George G. [1 ]
机构
[1] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA
关键词
EVALUATING DIAGNOSTIC-TESTS; QUALITY SPECIFICATIONS; CLINICAL INTERPRETATION; BIOLOGICAL VARIATION; REFERENCE INTERVALS; LABORATORY TESTS; TESTOSTERONE; BIAS; POPULATION; STRATEGIES;
D O I
10.1373/clinchem.2009.133660
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
BACKGROUND: Accrediting organizations require laboratories to establish analytic performance criteria that ensure their tests provide results of the high quality required for patient care. However, the procedures for instituting performance criteria that are directly linked to the needs of medical practice are not well established, and therefore alternative strategies often are used to create and implement surrogate performance standards. CONTENT: We reviewed 6 approaches for establishing outcome-related analytic performance goals: (a) limits defined by regulations and external assessment programs, (b) limits based on biologic variation, (c) limits based on surveys of clinicians about their needs, (d) limits based on effects on guideline driven medical decisions, (e) limits based on analysis of patterns for ordering follow-up clinical tests, and (f) limits based on formal medical decision models. Performance criteria were tabulated for 12 common chemistry analytes and 4 routine hematology tests. CONCLUSIONS: There is no consensus currently about the preferred methods for establishing medically necessary analytic performance limits. The various methods reviewed give considerably different performance limits. The analytic performance limits claimed by a laboratory should correspond to those limits that can be reliably maintained based on validated QC monitoring systems. These limits generally are larger than the observed CVs and bias parameters collected for assay validation. There is a major need for increased communication among laboratorians and clinicians on this topic, especially when the analytic performance limits that can be consistently maintained by a laboratory are inconsistent with the expectations of health care providers. (C) 2010 American Association for Clinical Chemistry
引用
收藏
页码:714 / 722
页数:9
相关论文
共 42 条
[1]   What information should manufacturers provide on their procedures? [J].
Bais, Renze .
CLINICAL CHEMISTRY, 2006, 52 (08) :1624-1625
[2]  
BARNETT RN, 1968, AM J CLIN PATHOL, V50, P671
[3]   A girl with goiter and inappropriate thyroid-stimulating hormone secretion - Commentary [J].
Burman, Kenneth D. .
CLINICAL CHEMISTRY, 2008, 54 (07) :1246-1247
[4]  
*CDC, CURR CLIA REG INCL A
[5]   A decision support system to facilitate management of patients with acute gastrointestinal bleeding [J].
Chu, Adrienne ;
Ahn, Hongshik ;
Halwan, Bhawna ;
Kalmin, Bruce ;
Artifon, Everson L. A. ;
Barkun, Alan ;
Lagoudakis, Michail G. ;
Kumar, Atul .
ARTIFICIAL INTELLIGENCE IN MEDICINE, 2008, 42 (03) :247-259
[6]   Variability of cortisol assays can confound the diagnosis of adrenal insufficiency in the critically ill population [J].
Cohen, Jeremy ;
Ward, Gregory ;
Prins, Johannes ;
Jones, Mark ;
Venkatesh, Bala .
INTENSIVE CARE MEDICINE, 2006, 32 (11) :1901-1905
[7]   Implementing the Stockholm Conference hierarchy of objective quality criteria in a routine laboratory [J].
Dhatt, Gurdeep S. ;
Agarwal, Mukesh M. ;
Bishawi, Bassarn ;
Gill, Janice .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2007, 45 (04) :549-552
[8]   Robustness metrics for measuring the influence of additive noise on the performance of statistical classifiers [J].
EgmontPetersen, M ;
Talmon, JL ;
Hasman, A .
INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS, 1997, 46 (02) :103-112
[9]   Proposals for setting generally applicable quality goals solely based on biology [J].
Fraser, CG ;
Petersen, PH ;
Libeer, JC ;
Ricos, C .
ANNALS OF CLINICAL BIOCHEMISTRY, 1997, 34 :8-12
[10]  
Fraser CG, 1999, CLIN CHEM, V45, P321